FDA Panel Unclear on Osteoporosis Drug Labels

FDA Panel: Osteoporosis Drugs Need Better Labels Time Limits on the Drugs Are Suggested, but How Much Time Is Yet to Be Determined WebMD Medical News By Rita Rubin Reviewed...

Click here to read the full story.

Post a Comment

No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.